Cancer of the Breast
49
10
12
18
Key Insights
Highlights
Success Rate
60% trial completion
Published Results
13 trials with published results (27%)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 75/100
24.5%
12 terminated out of 49 trials
60.0%
-26.5% vs benchmark
2%
1 trials in Phase 3/4
72%
13 of 18 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 18 completed trials
Clinical Trials (49)
Collection of CSF Samples From Participants With Metastatic Triple Negative Breast Cancer (TNBC) and HER2+ Breast Cancer With no Prior History Nor Active Radiographically Detectable Brain Metastases
Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence Score
Precision Supplemental Imaging in Women With Dense Breasts
Treatment Monitoring of Patients Receiving CDK 4/6 Inhibitors for Hormone Receptor (HR) Positive, HER2 Negative Metastatic Breast Cancer (MBC) With or Without the Addition of DiviTum® Serum Thymidine Kinase 1 (TK1) Activity Testing
ChatGPT & Surgeon Synergy: Redefining Breast Reconstruction Consultations for Enhanced Patient Engagement and Satisfaction
A Synthetic Lethality-Focused Algorithm to Identify Therapeutic Options in Advanced Metastatic Breast Cancer (SYNTHESIS-Breast)
Overcoming Racial Disparities in Screening Mammography
COOL-IT-PRO: Cryoablation of Breast Cancer in Non-surgical Patients
NeoTAILOR: ABiomarker-directed Approach to Guide Neoadjuvant Therapy for Patients With Stage II/III ER-positive, HER2-negative Breast Cancer
Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment Disorder
Breast Re-irradiation After Second Ipsilateral Lumpectomy
Axillary Reverse Mapping
NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors
DAANCE FOR CHEMOTHERAPY-INDUCED NEUROPATHY
Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
Proton Radiation for Stage II/III Breast Cancer
Prehabilitation to Revolutionize Oncology: Telehealth Exercise for Cognitive Triumphs (The PROTECT Trial)
Real-time Intraoperative Breast Cancer Visualization for Margin Assessment
Vocorder Device Validation in Clinical Settings - Continuous Monitoring of Individuals (Vocorder Clinical Validation-VCV)
Mental and Cognitive Health and Physical Activity in the Perioperative Breast Cancer Setting